Latest news

Journal newsletter sent to subscribers in week 37, 2009. Follow link to see newsletter summary.  Register to receive newsletters.

Journal newsletter sent to subscribers in week 36, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 34, 2009. Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 32, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 28, 2009. Register to receive future newsletters.

Read the call for papers from Editor in Chief Dr Goberdhan Dimri

Journal newsletter sent to subscribers in week 23, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 15, 2009.  Register to receive future newsletters. 

Journal newsletter sent to subscribers in week 13, 2009.  Register to receive future newsletters.

Peer reviewers are sought. Click here to apply or update your details.

Journal overview

Aims and scope:

Breast Cancer: Basic and Clinical Research is an international, open access, peer reviewed journal which considers manuscripts on all areas of breast cancer research and treatment. These areas include: breast cancer biology and pathogenesis, clinical interventions, and epidemiology and population genetics.

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by:

• Google Scholar
• CAS
• DOAJ
• OAIster

SPARC Europe Seal award winner:

This journal has been awarded a SPARC Europe Seal. The Seal is an initiative of SPARC Europe (Scholarly Publishing and Academic Resources Coalition) and the Directory of Open Access Journals (DOAJ) which is awarded to journals applying a Creative Commons CC-BY copyright license and that make journal metadata accessible to DOAJ.  

Amongst other important services DOAJ makes metadata OAI-compliant.  This in turn enhances the visibility of papers and allows OAI-harvesters to include the details of journal articles in their services. We encourage readers to make use of this valuable resource.  The DOAJ search page is available here.

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

Call for papers:

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
  
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.

Editor in Chief profile

Dr Goberdhan P. Dimri is an Assistant Professor of Medicine at the Department of Medicine, Feinberg School of Medicine, and a member of Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL. He is also an Assistant Professor of Medicine and Senior Scientist at the Evanston Northwestern Healthcare Research Institute, Evanston, IL. He received his Ph.D. in Environmental Sciences from J. N. University, New Delhi, India, and his postdoctoral training in Cancer Biology at the Lawrence Berkeley National Laboratory, University of California at Berkeley, CA. Prior to coming to Northwestern University, Dr. Dimri was an Assistant Professor of Radiation Oncology at the New England Medical Center, Tufts University, Boston, MA.

He is the author of over forty peer reviewed articles and reviews. He has received numerous honors and awards during his career and is the member of numerous professional bodies. He has served as peer review panel member for various national and international grant funding agencies. He also serves as an ad-hoc reviewer for cancer biology related journals. His expertise is in the field of cancer and aging, particularly breast cancer. His laboratory is studying the role of polycomb proteins and senescence regulatory genes in the progression of breast cancer.

>> Dr Dimri's latest call for papers

Editorial Board

Lucile L. Adams-Campbell, PhD
Director, Cancer Center & Professor of Medicine, Howard University Cancer Center, Washington, DC, USA

Vimla Band, PhD
Professor and Vice Chair of Research, Genetics, Cell Biology and Anatomy, University fo Nebraska Medical Centre, Omaha, NE, USA.

Alakananda Basu, PhD
Professor, Department of Molecular Biology & Immunology, Graduate Advisor, Cancer Biology, University of North Texas Health Science Center, Fort Worth, TX, USA

Stephen A. Boppart, MD, PhD
Director, Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, Illinois, USA
Associate Professor, Departments of Electrical and Computer Engineering, Bioengineering, and Medicine, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, USA

Amy H. Bouton, PhD
Professor, Department of Microbiology, University of Virginia School of Medicine Charlottesville, Virginia, USA

Mai N. Brooks, MD, FACS
Associate Professor, Department of Surgery, Division of Oncology University of California, Los Angeles, California, USA

Weibo Cai, PhD
Assistant Professor, Radiology, University of Wisconsin, Madison, WI, USA

Srikumar P. Chellappan, PhD
Professor, Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Robert Clarke, PhD, DSc
Professor of Oncology and Physiology & Biophysics W405A Research Bldg Georgetown University School of Medicine NW, Washington, DC, USA

Donald C. Cooper, PhD
Assistant Professor, Dept of Psychiatry, University of Texas Southwestern Medical Center Dallas, Texas, USA

Steven J. Danish, PhD
Director, Life Skills Center and Counseling Psychology Doctoral Program
Professor of Psychology and Social and Behavioral Health, Virginia Commonwealth University, Williams House, Richmond, VA, USA

Wendy Demark-Wahnefried, PhD, RD, LDN
Professor, School of Nursing and Department of Surgery, Duke University Medical Center, Durham, NC, USA

Paul Dent, PhD
Professor, Vice Chair, Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia, USA

Daniel C. Flynn, PhD
Deputy Director, MBR Cancer Center, Professor, Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV, USA

Qingshen Gao, PhD
Assistant Professor, Evanston Northwestern Healthcare Research Institute, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA

Sandra J. Gendler, PhD
Professor and Consultant, Dept. of Biochemistry/Molecular Biology Mayo Clinic College of Medicine, Scottsdale, AZ, USA

Professor of Pathology, University of Alabama at Birmingham, Birmingham, USA

Kalpna Gupta, PhD
Assistant Professor, Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA

Angela M. Hartley Brodie, PhD
Dept Pharmacology & Experimental Therapeutics, School of Medicine, University of Maryland, Baltimore, USA

Daniel F. Hayes, MD
Clinical Director, Breast Oncology Program University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA

Sue P. Heiney, PhD, RN, CS, FAAN
Associate Professor, Neuropsychiatry, School of Medicine, University of South Carolina, Columbia, SC, USA

Dorothee Herlyn, DVM, DSc
Professor, The Wistar Institute, Philadelphia, PA, USA

Allan D. Hess, PhD
Professor of Oncology, Pathology and Immunology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, Maryland, USA

Leena Hilakivi-Clarke, PhD
Professor of Oncology, Co-Chair, Division of Molecular Endocrinology, Nutrition & Obesity Director, Tumor Biology Master’s Program, and Shared Animal Resources Core Georgetown University Research Bldg, NW, Washington, USA

Steven M. Hill, PhD
Professor and Chair, Edmond & Lily Safra Chair for Breast Cancer Research Department of Structural & Cellular Biology Tulane University School of Medicine, New Orleans, LA, USA

Jennifer J. Hu, PhD
Professor, Department of Epidemiology and Public Health, Associate Director, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA

Huabei Jiang, PhD
Professor, Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA

Zhila Khalkhali-Ellis, PhD
Research Associate Professor, Children’s Memorial Research Center, Chicago, IL, USA

H. Phillip Koeffler, MD
Director, Hematology/Oncology, Professor of Medicine, Department of Medicine, Hematology/Oncology Division, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, California, USA

Robert A. Kurt, PhD
Associate Professor, Department Biology, Lafayette College, Easton, PA, USA

Zibo Li, PhD
Assistant Professor, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Lee Jane W Lu, PhD
Professor, Division of Human Nutrition, Department of Preventive Medicine and Community Health, The University of Texas Medical Branch, Galveston, TX, USA

Mia Markey, PhD
Assistant Professor, The University of Texas, Department of Biomedical Engineering, Austin, TX, USA

Rajendra G. Mehta, PhD
Assistant Vice President, Head, Carcinogenesis and Chemoprevention Division Head, Drug Discovery Division IIT Research Institute Professor, Biological Sciences, Chicago, IL, USA

Kathleen M. Mulder, PhD
Professor, Department of Pharmacology, Penn State College of Med, Hershey, PA, USA

Rita Nahta, PhD
Assistant Professor, Pharmacology, Emory University, Atlanta, GA, USA

William George North, PhD
Professor of Physiology, Dartmouth Medical School, Lebanon, New Hampshire, USA
Professor of Biochemistry and Molecular Biology, University of New Hampshire, and Senior Faculty Member, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Michele Pagano, PhD
Department of Pathology and NYU Cancer Institute New York University, School of Medicine, New York, NY, USA

Ajay Rana, PhD
Associate Professor, Department of Pharmacology, Loyola University Medical Center, Maywood, IL, USA

Professor Armen Sarvazyan, PhD, DSc
Chief Scientist of Artann Laboratories, West Trenton, New Jersey, USA

Kazuhiko Sato, MD, PhD
Director, Breast Oncology Center, Tokyo West Tokushukai Hospital, Akishima, Tokyo, Japan

Victoria L. Seewaldt, PhD
Associate Professor, Department of Medicine, Division of Oncology, Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC

Michael A. Tainsky, PhD
Barbara & Fred Erb Professor of Cancer Genetics Department of Pathology Director, Program in Molecular Biology and Genetics Karmanos Cancer Institute Wayne State University School of Medicine, Detroit, MI

Paul O.P. Ts’o, PhD
Managing Director and Founder, CCC Diagnostics LLC, Caton Research Center, Baltimore, MD, USA

Valerie Marie Weaver, PhD
Associate Professor, Departments of Surgery and Anatomy and Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. Director, Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, CA, USA

Join an editorial board or update your details:

Related journals